Skip to the page

Data / Drug companies / Advagen Pharma Ltd

Advagen Pharma Ltd: 218 products in the FDA NDC directory, labeler code 72888

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Advagen Pharma Ltd (labeler code 72888) lists 218 products in the FDA National Drug Code Directory, covering 75 finished drugs by generic name. By type: 212 prescription drugs, 6 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 28, 2026.

The request: Watch Advagen Pharma Ltd (FDA labeler code 72888): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72888
Products in commercial distribution
218
Packages
522
Finished drugs by generic name
75
Prescription products
212
Over the counter products
6
Controlled substance products
Schedule III 4, Schedule IV 13, Schedule V 3
Flagged as original packager
193 of 193 products that carry the flag
Started marketing in the last 12 months
19
Earliest marketing start
November 16, 2000
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)21196.8%
Authorized generics (NDA)62.8%
Over the counter monograph drugs10.5%

Products by type

TypeProductsShare
Prescription drugs21297.2%
Over the counter drugs62.8%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Metoprolol tartrate1146
Potassium chloride984
Baclofen965
Clonazepam936
Carvedilol835
Dexamethasone745
Oxcarbazepine746
Amitriptyline hydrochloride635
Guanfacine633
Isosorbide dinitrate518
Carbidopa and levodopa541
Buspirone hydrochloride550
Tizanidine hydrochloride425
Sildenafil453
Glipizide439
Lamotrigine451
Buprenorphine hydrochloride410
Labetalol hydrochloride443
Tramadol hydrochloride444
Venlafaxine hydrochloride448
Diclofenac sodium4109
Pregabalin354
Gabapentin391
Benazepril hydrochloride and hydrochlorothiazide37
Topiramate356
Amiodarone hydrochloride335
Desvenlafaxine314
Oxybutynin chloride345
Primidone323
Diclofenac potassium342
Bumetanide342
Metolazone322
Midodrine hydrochloride334
Dicyclomine hydrochloride350
Cyclobenzaprine hydrochloride361
Nitroglycerin340
Bisoprolol fumarate325
Ivermectin233
Triamterene and hydrochlorothiazide227
Ipratropium bromide223
Mycophenolate mofetil237
Triamterene24
Mycophenolic acid216
Chlorpromazine hydrochloride227
Nicotine polacrilex257
Acetazolamide237
Dorzolamide hydrochloride111
Ciprofloxacin hydrochloride136
Lithium15
Hydroxyzine hydrochloride151
Fluticasone propionate nasal11
Rabeprazole sodium120
Loperamide hydrochloride182
Levofloxacin142
Haloperidol132
Tranexamic acid139
Cevimeline hydrochloride116
Lidocaine hydrochloride1134
Pentoxifylline19
Atomoxetine hydrochloride18
Ibuprofen1190
Spironolactone and hydrochlorothiazide19
Aripiprazole149
Promethazine hydrochloride and dextromethorphan hydrobromide112
Nortriptyline hydrochloride129
Cetirizine hydrochloride1119
Amantadine hydrochloride132
Acetaminophen1214
Loratadine1125
Fluticasone propionate171
Valsartan oral11
Acyclovir170
Dihydroergotamine mesylate113
Clomiphene citrate18
Hydrochlorothiazide151

Dosage forms

Dosage formProductsShare
Tablet8739.9%
Tablet, film coated3616.5%
Solution198.7%
Tablet, extended release156.9%
Capsule146.4%
Tablet, coated73.2%
Tablet, film coated, extended release62.8%
Tablet, delayed release62.8%
Tablet, orally disintegrating62.8%
Capsule, extended release41.8%
Suspension41.8%
Spray31.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Triamterene72888-505CapsuleGeneric drugs (ANDA)October 28, 2026
Triamterene72888-504CapsuleGeneric drugs (ANDA)October 28, 2026
Hydrochlorothiazide72888-491SolutionGeneric drugs (ANDA)October 7, 2026
Pentoxifylline72888-268TabletAuthorized generics (NDA)October 1, 2026
Diclofenac Potassium72888-203Tablet, coatedGeneric drugs (ANDA)September 18, 2026
Hydroxyzine Hydrochloride72888-218SolutionGeneric drugs (ANDA)September 11, 2026
Spironolactone and hydrochlorothiazide72888-040TabletGeneric drugs (ANDA)September 10, 2026
Dicyclomine hydrochloride72888-105CapsuleGeneric drugs (ANDA)July 17, 2026
Promethazine Hydrochloride and Dextromethorphan Hydrobromide72888-038SolutionGeneric drugs (ANDA)June 23, 2026
Clonazepam72888-497TabletGeneric drugs (ANDA)June 12, 2026
Clonazepam72888-137Tablet, orally disintegratingGeneric drugs (ANDA)May 21, 2026
Clonazepam72888-136Tablet, orally disintegratingGeneric drugs (ANDA)May 21, 2026
Clonazepam72888-135Tablet, orally disintegratingGeneric drugs (ANDA)May 21, 2026
Clonazepam72888-134Tablet, orally disintegratingGeneric drugs (ANDA)May 21, 2026
Clonazepam72888-133Tablet, orally disintegratingGeneric drugs (ANDA)May 21, 2026
Atomoxetine hydrochloride72888-456SolutionAuthorized generics (NDA)March 20, 2026
Childrens ibuprofen72888-479SuspensionGeneric drugs (ANDA)March 5, 2026
Cetirizine hydrochloride72888-480SolutionGeneric drugs (ANDA)February 25, 2026
Buprenorphine hydrochloride72888-510TabletGeneric drugs (ANDA)February 1, 2026
Dexamethasone72888-241TabletGeneric drugs (ANDA)October 15, 2025
Dexamethasone72888-240TabletGeneric drugs (ANDA)October 15, 2025
Dexamethasone72888-239TabletGeneric drugs (ANDA)October 15, 2025
Dexamethasone72888-238TabletGeneric drugs (ANDA)October 15, 2025
Dexamethasone72888-237TabletGeneric drugs (ANDA)October 15, 2025
Dexamethasone72888-236TabletGeneric drugs (ANDA)October 15, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.